Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency

Nature Medicine, Published online: 26 August 2025; doi:10.1038/s41591-025-03913-2

Analyzing data from the SURMOUNT-1 trial, the authors show that the weight loss effects of tirzepatide treatment are similar in carriers and noncarriers of MC4R pathogenic mutations.